TGFB1 and neoplasm: TGF-β1 has been shown to suppress tumor development in a time- and dose-dependent manner, by blocking the cell cycle (G1-phase arrest), via increasing cyclin-dependent kinase (cdks) inhibitor levels [240, 241].